{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T21:43:30Z","timestamp":1791582210267,"version":"4.3.4"},"reference-count":57,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Problems in Pediatric and Adolescent Health Care"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1016\/j.cppeds.2021.101033","type":"journal-article","created":{"date-parts":[[2021,7,17]],"date-time":"2021-07-17T01:53:47Z","timestamp":1626486827000},"page":"101033","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["New diagnostic and therapeutic modalities in neuromuscular disorders in children"],"prefix":"10.1016","volume":"51","author":[{"given":"Mahesh","family":"Chikkannaiah","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irma","family":"Reyes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.cppeds.2021.101033_bib0001","first-page":"55","article-title":"Integrated diagnostic approach of pediatric neuromuscular disorders","volume":"15","author":"Lee","year":"2018","journal-title":"J Gen Med"},{"issue":"3","key":"10.1016\/j.cppeds.2021.101033_bib0002","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.pmr.2012.06.011","article-title":"Clinical approach to the diagnostic evaluation of hereditary and acquired neuromuscular diseases","volume":"23","author":"McDonald","year":"2012","journal-title":"Phys Med Rehabil Clin N Am"},{"key":"10.1016\/j.cppeds.2021.101033_bib0003","unstructured":"Darras, BJJ, H. Royden; Ryan, MM; De Vivo, Darryl, Neuromuscular disorders of infancy, childhood, and adolescence: a Clinician's approach. 2nd ed. 2015: Elsevier"},{"issue":"1","key":"10.1016\/j.cppeds.2021.101033_bib0004","first-page":"S89","article-title":"Neuromuscular diseases: Diagnosis and management","volume":"104","author":"Mary","year":"2018","journal-title":"Orthopaed Traumatol"},{"issue":"4","key":"10.1016\/j.cppeds.2021.101033_bib0005","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/S0887-8994(00)00202-2","article-title":"Diagnosis of pediatric neuromuscular disorders in the era of DNA analysis","volume":"23","author":"Darras","year":"2000","journal-title":"Pediatr Neurol"},{"issue":"4","key":"10.1016\/j.cppeds.2021.101033_bib0006","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1002\/ajmg.a.38418","article-title":"Treating pediatric neuromuscular disorders: The future is now","volume":"176","author":"Dowling","year":"2018","journal-title":"Am J Med Genet A"},{"issue":"6","key":"10.1016\/j.cppeds.2021.101033_bib0007","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/S1474-4422(20)30028-4","article-title":"Advances in the diagnosis of inherited neuromuscular diseases and implications for therapy development","volume":"19","author":"Thompson","year":"2020","journal-title":"Lancet Neurol"},{"issue":"11","key":"10.1016\/j.cppeds.2021.101033_bib0008","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/j.nmd.2019.08.011","article-title":"MYO-MRI diagnostic protocols in genetic myopathies","volume":"29","author":"Warman Chardon","year":"2019","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.cppeds.2021.101033_bib0009","article-title":"Muscle MRI for Neuromuscular Disorders","author":"Nicolau","year":"2020","journal-title":"Practic Neurol"},{"issue":"4","key":"10.1016\/j.cppeds.2021.101033_bib0010","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1002\/ana.22510","article-title":"Prevalence of congenital myopathies in a representative pediatric united states population","volume":"70","author":"Amburgey","year":"2011","journal-title":"Ann Neurol"},{"issue":"2","key":"10.1016\/j.cppeds.2021.101033_bib0011","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.nmd.2013.11.003","article-title":"Approach to the diagnosis of congenital myopathies","volume":"24","author":"North","year":"2014","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.cppeds.2021.101033_bib0012","first-page":"7","article-title":"Recent advances in understanding congenital myopathies","author":"Ravenscroft","year":"2018","journal-title":"F1000Res"},{"issue":"3","key":"10.1016\/j.cppeds.2021.101033_bib0013","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1177\/0883073812436605","article-title":"Consensus statement on standard of care for congenital myopathies","volume":"27","author":"Wang","year":"2012","journal-title":"J Child Neurol"},{"issue":"3","key":"10.1016\/j.cppeds.2021.101033_bib0014","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S1474-4422(18)30024-3","article-title":"Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and neuromuscular, rehabilitation, endocrine, and gastrointestinal and nutritional management","volume":"17","author":"Birnkrant","year":"2018","journal-title":"Lancet Neurol"},{"issue":"3","key":"10.1016\/j.cppeds.2021.101033_bib0015","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s11897-020-00456-0","article-title":"Duchenne Muscular Dystrophy: the Heart of the Matter","volume":"17","author":"Shih","year":"2020","journal-title":"Curr Heart Fail Rep"},{"issue":"3","key":"10.1016\/j.cppeds.2021.101033_bib0016","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1177\/1479972307080697","article-title":"Mechanical ventilation in Duchenne patients with chronic respiratory insufficiency: clinical implications of 20 years published experience","volume":"4","author":"Toussaint","year":"2007","journal-title":"Chron Respir Dis"},{"key":"10.1016\/j.cppeds.2021.101033_bib0017","unstructured":"Venugopal, V. and S. Pavlakis, Duchenne muscular dystrophy, in StatPearls. 2021: Treasure Island (FL)."},{"issue":"6","key":"10.1016\/j.cppeds.2021.101033_bib0018","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/0092-8674(87)90579-4","article-title":"Dystrophin: the protein product of the Duchenne muscular dystrophy locus","volume":"51","author":"Hoffman","year":"1987","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.cppeds.2021.101033_bib0019","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1002\/humu.22758","article-title":"The TREAT-NMD DMD Global Database: analysis of more than 7,000 Duchenne muscular dystrophy mutations","volume":"36","author":"Bladen","year":"2015","journal-title":"Hum Mutat"},{"issue":"12","key":"10.1016\/j.cppeds.2021.101033_bib0020","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1002\/humu.21114","article-title":"Mutational spectrum of DMD mutations in dystrophinopathy patients: application of modern diagnostic techniques to a large cohort","volume":"30","author":"Flanigan","year":"2009","journal-title":"Hum Mutat"},{"issue":"6","key":"10.1016\/j.cppeds.2021.101033_bib0021","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1002\/humu.20976","article-title":"Genotype-phenotype analysis in 2,405 patients with a dystrophinopathy using the UMD-DMD database: a model of nationwide knowledgebase","volume":"30","author":"Tuffery-Giraud","year":"2009","journal-title":"Hum Mutat"},{"issue":"4","key":"10.1016\/j.cppeds.2021.101033_bib0022","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1212\/WNL.39.4.465","article-title":"Molecular and clinical correlations of deletions leading to Duchenne and Becker muscular dystrophies","volume":"39","author":"Baumbach","year":"1989","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/j.cppeds.2021.101033_bib0023","first-page":"620","article-title":"Intragenic deletions in 21 Duchenne muscular dystrophy (DMD)\/Becker muscular dystrophy (BMD) families studied with the dystrophin cDNA: location of breakpoints on HindIII and BglII exon-containing fragment maps, meiotic and mitotic origin of the mutations","volume":"43","author":"Darras","year":"1988","journal-title":"Am J Hum Genet"},{"issue":"3","key":"10.1016\/j.cppeds.2021.101033_bib0024","doi-asserted-by":"crossref","first-page":"519","DOI":"10.2106\/00004623-200403000-00009","article-title":"Steroid treatment and the development of scoliosis in males with duchenne muscular dystrophy","volume":"86","author":"Alman","year":"2004","journal-title":"J Bone Joint Surg Am"},{"issue":"4","key":"10.1016\/j.cppeds.2021.101033_bib0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpeds.2013.05.060","article-title":"Oral corticosteroids and onset of cardiomyopathy in Duchenne muscular dystrophy","volume":"163","author":"Barber","year":"2013","journal-title":"J Pediatr"},{"issue":"1","key":"10.1016\/j.cppeds.2021.101033_bib0026","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1002\/mus.23808","volume":"48","author":"Henricson","year":"2013","journal-title":"Muscle Nerve"},{"issue":"13","key":"10.1016\/j.cppeds.2021.101033_bib0027","doi-asserted-by":"crossref","first-page":"e1312","DOI":"10.1212\/WNL.0000000000008168","article-title":"Vamorolone trial in Duchenne muscular dystrophy shows dose-related improvement of muscle function","volume":"93","author":"Hoffman","year":"2019","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.cppeds.2021.101033_bib0028","doi-asserted-by":"crossref","first-page":"43","DOI":"10.3233\/JND-180341","article-title":"Phase 1 study of Edasalonexent (CAT-1004), an Oral NF-kappaB Inhibitor, in pediatric patients with Duchenne muscular dystrophy","volume":"6","author":"Finanger","year":"2019","journal-title":"J Neuromuscul Dis"},{"key":"10.1016\/j.cppeds.2021.101033_bib0029","doi-asserted-by":"crossref","DOI":"10.1016\/j.spen.2021.100877","article-title":"Therapeutic Approaches for duchenne muscular dystrophy: old and new","volume":"37","author":"Mackenzie","year":"2021","journal-title":"Semin Pediatr Neurol"},{"issue":"4","key":"10.1016\/j.cppeds.2021.101033_bib0030","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/S1474-4422(18)30025-5","article-title":"Diagnosis and management of Duchenne muscular dystrophy, part 2: respiratory, cardiac, bone health, and orthopaedic management","volume":"17","author":"Birnkrant","year":"2018","journal-title":"Lancet Neurol"},{"issue":"9","key":"10.1016\/j.cppeds.2021.101033_bib0031","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1001\/jamaneurol.2020.1484","article-title":"Assessment of systemic delivery of raavrh74.mhck7.micro-dystrophin in children with Duchenne muscular dystrophy: a nonrandomized controlled trial","volume":"77","author":"Mendell","year":"2020","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.cppeds.2021.101033_bib0032","series-title":"ASGCT Annual Meeting","article-title":"Safety and tolerability of pf-06939926 in ambulatory boys with Duchenne muscular dystrophy: a phase 1b multicenter, OpenLabel. Dose Ascending Study","author":"Binks","year":"2020"},{"issue":"6410","key":"10.1016\/j.cppeds.2021.101033_bib0033","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1126\/science.aau1549","article-title":"Gene editing restores dystrophin expression in a canine model of Duchenne muscular dystrophy","volume":"362","author":"Amoasii","year":"2018","journal-title":"Science"},{"issue":"5","key":"10.1016\/j.cppeds.2021.101033_bib0034","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/S1474-4422(18)30026-7","article-title":"Diagnosis and management of Duchenne muscular dystrophy, part 3: primary care, emergency management, psychosocial care, and transitions of care across the lifespan","volume":"17","author":"Birnkrant","year":"2018","journal-title":"Lancet Neurol"},{"issue":"5","key":"10.1016\/j.cppeds.2021.101033_bib0035","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1002\/mus.25725","article-title":"Developing multidisciplinary clinics for neuromuscular care and research","volume":"56","author":"Paganoni","year":"2017","journal-title":"Muscle Nerve"},{"issue":"1","key":"10.1016\/j.cppeds.2021.101033_bib0036","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1136\/archdischild-2018-314837","article-title":"Myotonic dystrophy type 1: clinical manifestations in children and adolescents","volume":"104","author":"Ho","year":"2019","journal-title":"Arch Dis Child"},{"issue":"10","key":"10.1016\/j.cppeds.2021.101033_bib0037","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/S1474-4422(12)70204-1","article-title":"The myotonic dystrophies: molecular, clinical, and therapeutic challenges","volume":"11","author":"Udd","year":"2012","journal-title":"Lancet Neurol"},{"issue":"7","key":"10.1016\/j.cppeds.2021.101033_bib0038","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.nmd.2011.04.009","article-title":"A new window on neurocognitive dysfunction in the childhood form of myotonic dystrophy type 1 (DM1)","volume":"21","author":"Angeard","year":"2011","journal-title":"Neuromuscul Disord"},{"issue":"3","key":"10.1016\/j.cppeds.2021.101033_bib0039","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.ejpn.2007.07.014","article-title":"Myotonic dystrophy type I in childhood Long-term evolution in patients surviving the neonatal period","volume":"12","author":"Echenne","year":"2008","journal-title":"Eur J Paediatr Neurol"},{"issue":"4","key":"10.1016\/j.cppeds.2021.101033_bib0040","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1212\/01.WNL.0000054481.84978.F9","article-title":"Myotonic dystrophy type 2: molecular, diagnostic and clinical spectrum","volume":"60","author":"Day","year":"2003","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.cppeds.2021.101033_bib0041","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1002\/mus.20722","article-title":"Severity, type, and distribution of myotonic discharges are different in type 1 and type 2 myotonic dystrophy","volume":"35","author":"Logigian","year":"2007","journal-title":"Muscle Nerve"},{"issue":"4","key":"10.1016\/j.cppeds.2021.101033_bib0042","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1002\/mus.24766","article-title":"Relative risks for comorbidities associated with myotonic dystrophy: a population-based analysis","volume":"52","author":"Johnson","year":"2015","journal-title":"Muscle Nerve"},{"issue":"8","key":"10.1016\/j.cppeds.2021.101033_bib0043","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1212\/WNL.52.8.1658","article-title":"A 10-year study of mortality in a cohort of patients with myotonic dystrophy","volume":"52","author":"Mathieu","year":"1999","journal-title":"Neurology"},{"key":"10.1016\/j.cppeds.2021.101033_bib0044","unstructured":"Vydra, D.G. and A. Rayi, Myotonic dystrophy, in StatPearls. 2021: Treasure Island (FL)."},{"issue":"6","key":"10.1016\/j.cppeds.2021.101033_bib0045","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1212\/CON.0000000000000793","article-title":"Myotonic muscular dystrophies","volume":"25","author":"Johnson","year":"2019","journal-title":"Continuum (Minneap Minn)"},{"issue":"18","key":"10.1016\/j.cppeds.2021.101033_bib0046","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1212\/WNL.0b013e3181dc1a3a","article-title":"Mexiletine is an effective antimyotonia treatment in myotonic dystrophy type 1","volume":"74","author":"Logigian","year":"2010","journal-title":"Neurology"},{"issue":"R1","key":"10.1016\/j.cppeds.2021.101033_bib0047","doi-asserted-by":"crossref","first-page":"R55","DOI":"10.1093\/hmg\/ddz131","article-title":"Genetic approaches to the treatment of inherited neuromuscular diseases","volume":"28","author":"Ravi","year":"2019","journal-title":"Hum Mol Genet"},{"issue":"2","key":"10.1016\/j.cppeds.2021.101033_bib0048","doi-asserted-by":"crossref","DOI":"10.3390\/brainsci11020194","article-title":"In search of a cure: the development of therapeutics to alter the progression of spinal muscular atrophy","volume":"11","author":"Ojala","year":"2021","journal-title":"Brain Sci"},{"issue":"10","key":"10.1016\/j.cppeds.2021.101033_bib0049","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1056\/NEJMoa2009965","article-title":"Risdiplam in type 1 spinal muscular atrophy","volume":"384","author":"Baranello","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cppeds.2021.101033_bib0050","unstructured":"Nagappa, M, S. Sharma, and A.B. Taly, Charcot Marie Tooth, in StatPearls. 2021: Treasure Island (FL)."},{"issue":"6","key":"10.1016\/j.cppeds.2021.101033_bib0051","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2019-029240","article-title":"Prevalence of Charcot-Marie-Tooth disease across the lifespan: a population-based epidemiological study","volume":"9","author":"Theadom","year":"2019","journal-title":"BMJ Open"},{"key":"10.1016\/j.cppeds.2021.101033_bib0052","first-page":"235","article-title":"The genetics of Charcot-Marie-Tooth disease: current trends and future implications for diagnosis and management","volume":"8","author":"Hoyle","year":"2015","journal-title":"Appl Clin Genet"},{"issue":"2","key":"10.1016\/j.cppeds.2021.101033_bib0053","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1007\/s12035-012-8370-x","article-title":"The PMP22 gene and its related diseases","volume":"47","author":"Li","year":"2013","journal-title":"Mol Neurobiol"},{"issue":"14","key":"10.1016\/j.cppeds.2021.101033_bib0054","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20143419","article-title":"Charcot-marie-tooth: from molecules to therapy","volume":"20","author":"Morena","year":"2019","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.cppeds.2021.101033_bib0055","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4061\/2011\/404101","article-title":"Juvenile myasthenia gravis: a Paediatric perspective","volume":"2011","author":"Finnis","year":"2011","journal-title":"Autoimmune Diseases"},{"key":"10.1016\/j.cppeds.2021.101033_bib0056","unstructured":"Beloor Suresh, A. and R.M.D. Asuncion, Myasthenia gravis, in StatPearls. 2021: Treasure Island (FL)."},{"key":"10.1016\/j.cppeds.2021.101033_bib0057","unstructured":"Abicht, A, JS. Muller, and H. Lochmuller, Congenital myasthenic syndromes, in GeneReviews((R)), M.P. Adam, et\u00a0al., Editors. 1993: Seattle (WA)."}],"container-title":["Current Problems in Pediatric and Adolescent Health Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538544221000882?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538544221000882?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T02:21:19Z","timestamp":1761531679000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538544221000882"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":57,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2021,7]]}},"alternative-id":["S1538544221000882"],"URL":"https:\/\/doi.org\/10.1016\/j.cppeds.2021.101033","relation":{},"ISSN":["1538-5442"],"issn-type":[{"value":"1538-5442","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"New diagnostic and therapeutic modalities in neuromuscular disorders in children","name":"articletitle","label":"Article Title"},{"value":"Current Problems in Pediatric and Adolescent Health Care","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cppeds.2021.101033","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"101033"}}